The cost of drug development.

dc.contributor.author

DiMasi, Joseph A

dc.contributor.author

Grabowski, Henry G

dc.contributor.author

Hansen, Ronald W

dc.coverage.spatial

United States

dc.date.accessioned

2016-09-13T07:48:34Z

dc.date.issued

2015-05-14

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/25970070

dc.identifier.eissn

1533-4406

dc.identifier.uri

https://hdl.handle.net/10161/12747

dc.language

eng

dc.publisher

Massachusetts Medical Society

dc.relation.ispartof

N Engl J Med

dc.relation.isversionof

10.1056/NEJMc1504317

dc.subject

Drug Costs

dc.subject

Drug Discovery

dc.subject

Drug Industry

dc.subject

Financing, Government

dc.title

The cost of drug development.

dc.type

Journal article

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/25970070

pubs.begin-page

1972

pubs.issue

20

pubs.organisational-group

Duke

pubs.organisational-group

Economics

pubs.organisational-group

Trinity College of Arts & Sciences

pubs.publication-status

Published

pubs.volume

372

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
DiMasi et al NEJM letter_May 14_2015.pdf
Size:
275.66 KB
Format:
Adobe Portable Document Format
Description:
Published version